AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | – | 116 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 116 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | – | 116 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 116 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 116 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 116 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 116 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 116 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 116 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 116 | -24.7% | 0.00% | – |
| Q1 2020 | $2,000 | -60.0% | 154 | -24.5% | 0.00% | – |
| Q4 2019 | $5,000 | – | 204 | +363.6% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 44 | +15.8% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 38 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 38 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 38 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 38 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 38 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 38 | +72.7% | 0.00% | – |
| Q4 2017 | $2,000 | +100.0% | 22 | -56.9% | 0.00% | – |
| Q4 2015 | $1,000 | -97.8% | 51 | -98.0% | 0.00% | – |
| Q3 2015 | $46,000 | +1433.3% | 2,595 | +1702.1% | 0.00% | – |
| Q2 2015 | $3,000 | -75.0% | 144 | -71.2% | 0.00% | – |
| Q2 2014 | $12,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |